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httpcense.Abstract The aim of this study is to evaluate the role of diffusion-weighted magnetic resonance
imaging in differentiation between benign and malignant hepatic focal lesions.
Patients and methods: Fifty-ﬁve hepatic focal lesions in 40 patients. All those patients were sub-
jected to full clinical evaluation and radiological assessment using conventional MRI study of
the liver and diffusion-weighted MRI (Different b values: 100, 500 and 750 s/mm2). All lesions were
evaluated regarding size, signal intensity, enhancement pattern, qualitative assessments by the dif-
ferent b values and quantitative assessment by measurement of the ADC values.
Results: ADCs of focal hepatic lesions were signiﬁcantly different between benign (2.869 ·
103 mm2/s ± 0.652) and malignant (0.995 · 103 mm2/s ± 0. 274) hepatic focal lesions. The mean
ADCs were 0.76 · 103 mm2/s ± 0.53 for metastases, 1.3 · 103 mm2/s ± 0.55 for HCCs, 1.95 · 10
3 mm2/s ± 0.24 for benign hepatocellular lesions, 2.92 · 103 mm2/s ± 0.102 for hemangiomas,
and 3.64 · 103 mm2/s ± 0.14 for cysts.
Conclusion: Diffusion-weighted imaging (DWI) offers the possibility to obtain criteria for charac-
terization of focal liver lesions with subsequent differentiation between benign and malignant hepa-
tic focal lesions without the need for contrast agent administration-by quantifying diffusion effects
via apparent diffusion coefﬁcient (ADC) measurements.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.331423.
com (M. Hamesa).
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Diffusion is the thermally induced motion of water molecules
in biologic tissues, called Brownian motion. The microscopic
motion includes molecular diffusion of water and microcircu-
lation of blood in the capillary network (microperfusion). With
the addition of diffusion gradient pulses, magnetic resonance
(MR) imaging by means of apparent diffusion coefﬁcientgyptian Society of Radiology and Nuclear Medicine.
.06.003
454 M.E. Badawy et al.(ADC) measurement is currently the best imaging method for
in vivo quantiﬁcation of the combined effects of capillary per-
fusion and diffusion (1,2).
The primary application of diffusion-weighted MR imaging
has been in brain imaging, mainly for the evaluation of acute
ischemic stroke, intracranial tumors, and demyelinating dis-
ease (3,4). With the advent of the echo-planar MR imaging
technique, diffusion weighted MR imaging of the abdomen
has become possible with fast imaging times, which minimizes
the effect of gross physiologic motion from respiration and
cardiac movement (9,12).
DWI (diffusion-weighted imaging) is a simple and sensitive
method for screening focal hepatic lesion and is useful for dif-
ferential diagnosis. With advances in software, hardware and
coil systems, diffusion-weighted (DW) MR imaging can now
be applied to liver imaging with improved image quality, prop-
er lesion detection and characterization. DW MR imaging en-
ables qualitative and quantitative assessment of tissue
diffusivity (apparent diffusion coefﬁcient) without the use of
gadolinium chelates, which makes it a highly attractive tech-
nique, particularly in patients with renal dysfunction at risk
for nephrogenic systemic ﬁbrosis (5).
With regard to focal liver lesions, DW imaging is able to
differentiate lesions with high water content (cysts and angio-
mas) from solid lesions. With regard to the latter, although
there are differences between benign lesions [focal nodular
hyperplasia (FNH), adenoma] and malignant lesions [metasta-
sis, hepatocellular carcinoma (HCC) in their apparent diffu-
sion coefﬁcient (ADC) (6).
Diffusion weighted technique should be used as an addi-
tional sequence to supplement conventional MRI protocol
studies for proper characterization of focal liver lesions (7).
The purpose of this study was to evaluate the ability of dif-
fusion-weighted magnetic resonance imaging in differentiation
between benign and malignant hepatic focal lesions.
2. Patients and methods
2.1. Patients
This study was conducted on (40) patients over a period of
12 months starting from May 2011 to May 2012. Those pa-
tients were referred to Diagnostic Radiology Department at
Tanta University Hospital from the different medical and sur-
gical departments as well as oncology unit of Tanta University
Hospital.
Informed consent was obtained from all patients after full
explanation of the beneﬁts and risks of the procedure. All pa-
tients were subjected to full clinical evaluation and speciﬁc lab-
oratory investigations. All patients performed abdominal US
and MRI study for the liver.
2.2. Liver MRI imaging protocol
All MR images were obtained on the available 1.5-T supercon-
ductingMRI scanner (SignaHD · 14.0,GEHealthcare) installed
at radiology department at Tanta university hospital as follows:
1. Unenhanced axial T1-weighted acquisitions Parameters are
repetition time (TR) 150–200/ms, echo time (TE) minimum,optional fat suppression, matrix, 256_192, 3/4 ﬁeld of view,
8_2 mm, respiratory gating.
2. T1 (Axial 2D breath hold spoiled GRE sequence applied in
phase and out of phase) (repetition time ms/echo time ms,
126/4.6 [in-phase], 2.3 [out-of-phase]; ﬂip angle, 80; matrix,
179_256; section thickness, 8 mm; intersection gap, 2.5 mm;
one signal acquired; ﬁeld of view, 320 mm).
3. Axial & Coronal T2-weighted fast spin-echo sequence with
spectral fat saturation (1800/85; fast spin-echo factor, 16;
matrix, 512_512; section thickness, 8 mm; intersection
gap, 2.5 mm; two signals acquired; ﬁeld of view, 320 mm).
Respiratory trigger, superior/inferior saturation bands,
32 kHz, fat suppression.
4. Heavily T2-weighted pulse sequences obtained with a mini-
mum TE of 160 ms.
5. Diffusion weighted sequences (Respiratory-triggered proto-
col using b value = 0, 100, 500 and 750). Before contrast
material injection, diffusion-weighted MR sequences were
performed with the single shot echo-planar imaging tech-
nique (EPI). These sequences combined diffusion gradient
pulses before and after the 180 pulse. Spectral fat satura-
tion was used systematically to exclude chemical shift arti-
facts. Qualitative assessments by the different b values as
well as quantitative assessment by measurement of the
ADC values were done.
6. Dynamic contrast material–enhanced (Gd-DTPA) imaging
(Axial 3D GRE T1). Axial dynamic 3D fat-suppressed
GRE sequence, LAVA [liver acquisition with volume
acceleration] section thickness, 4–8 mm, interpolated to
about 60 overlapping reconstructed sections of 2–4 mm
each; bandwidth, 62 kHz): Performed during all phases
after bolus injection of 0.2 mL/kg body weight of Gd-
DTPA ﬂushed with 20 ml of sterile 0.9% saline solution
from the antecubital vein. At 20 s (arterial phase), 40 s
(portal phase) 60 s (Venous phase), and 120 s (equilib-
rium phase) after the injection of Gd. And again at
10 min and may be variable up to 1 h after injection
(delayed phase).
The diagnosis of the cases was established by means of
typical MRI ﬁndings (specially the pattern of enhancement),
speciﬁc laboratory investigation and favorable clinical data.
The histopathological conﬁrmation was done for ﬁfteen atyp-
ical lesions by the mean of ultrasound & CT guided biopsy.
(See Figs. 1–4 and Tables 1–3) (See Chart 1).
2.3. Statistical analysis
Data were analyzed using Statistical Program for Social Sci-
ence (SPSS) version 17.0. Quantitative data were expressed
as mean ± stander deviation (SD).
The following tests were done:
n Independent-samples T test of signiﬁcance was used when
comparing between two means.
n A one-way analysis of variance (ANOVA) when comparing
between more than two means.
Probability (P-value) less than 0.05 was considered signiﬁ-
cant and less than 0.01 was considered as highly signiﬁcant.
Fig. 1 Female patient aged 50 years old presented with an accidentally discovered hypoechoic hepatic focal lesion upon fatty liver during
US check up. MRI study revealed a Lobulated left hepatic lobe subcapsular focal lesion showing hyperintense SI on T2 and heavy T2
weighted images (A and B). The lesion appeared hyperintense on diffusion study (C) as well as at the ADC map (D) with mean ADC
value = 2.9 · 103 mm2/s. The lesion showed incomplete ring of peripheral nodular enhancement at the arterial phase (E) after contrast
injection with gradual ﬁlling at the portal phase (F) and complete ﬁlling with contrast at delayed images (G). The lesion showed the typical
MRI ﬁndings of the hemangioma.
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Fig. 2 Female patient aged 65 years old presented with accidentally discovered right hepatic lobe mass upon cirrhotic liver during US
follow up and elevated a – fetoprotein up to 600 ng/ml. MRI study revealed a right hepatic lobe mass with maximal diameter = 5 cm, the
mass exhibits hypointense SI on T1- wi (A) and hyperintense SI on T2wi (B) and diffusion study(C) and hypointense on ADC map (D)
with mean ADC value = 1.34 · 103 mm2/s. The mass showed immediate heterogeneous enhancement at the arterial phase (E) with rapid
washout at the subsequent porto-venous (F) and delayed phases (G). The mass showed the typical MRI ﬁndings of HCC together with
histopathological conﬁrmation after surgical excision (Right lobectomy).
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Fig. 3 Female patient with cancer colon aged 40 years old presented with jaundice and elevated liver enzymes. MRI study ﬁndings: The
liver showed two well deﬁned focal lesions, one at the 4a segment and the other at the 8th segment. The lesions exhibits hypointense SI on
T1wi (A) and hyperintense SI on T2wi (B), diffusion study (C) and hypointense on ADC map (D) with mean ADC
value = 0.695 · 103 mm2/s. The mass showed marginal enhancement after Gd-DTPA administration (E). The diagnosis was established
as hypovascular metastasis based on the clinical history and the MRI ﬁndings.
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This study included ﬁfty-ﬁve hepatic focal lesions in 40 pa-
tients, they included 19 lesions of hepatic metastasis from dif-
ferent primary malignancies, 14 lesions of HCC, 7 lesions of
hemangioma, 4 lesions of CCA, 4 lesions of FNH, 3 simple he-
patic cyst, 2 hydatid cyst, one hepatic adenoma and one case of
hepatic lymphoma.
On diffusion studies All cystic lesions showed facilitated dif-
fusion, where they showed reduction of signal intensity on
increasing the b-values, and those which did not show reduc-
tion of signal showed high signal on ADC map, which also re-
ﬂects facilitated diffusion. On the other hand all malignant
solid lesions showed restricted diffusion evidenced by increased
signal on increasing the b-values and low signal on ADC maps.
4. Discussion
During the last two decades, technical developments have dra-
matically improved the quality of liver MRI. These include in-creases in ﬁeld strength, more powerful gradients, and more
sensitive receiver coils, all of which contribute to substantially
improved spatial resolution in the images with subsequent
accurate, noninvasive detection and characterization of hepa-
tic lesions (8,9).
The characterization of focal hepatic lesions continues to be
a challenge. Magnetic resonance (MR) imaging plays an
important role in the evaluation of a wide range of benign
and malignant focal hepatic lesions (10).
Recently, diffusion-weighted MR sequences have been
proposed for the characterization of focal hepatic lesions
by using single-shot echo-planar imaging (EPI) technique
with diffusion gradients in three directions and with different
b values (11).
The aim of this study was to evaluate the role of diffusion-
weighted magnetic resonance imaging in differentiation be-
tween benign and malignant hepatic focal lesions. This study
included ﬁfty-ﬁve hepatic focal lesions in 40 patients, they in-
cluded 19 lesions of hepatic metastasis from different primary
malignancies, 14 lesions of HCC, 7 lesions of hemangioma, 4
lesions of CCA, 4 lesions of FNH, 3 simple hepatic cyst, 2
Fig. 4 Male patient aged 65 years old presented with accidentally discovered hepatic focal lesion during US check up. MRI Findings:
The liver showed a well deﬁned focal lesion at the 4a segment with central area of necrosis, the lesion exhibits hypointense SI on T1WI (A),
Hyperintense SI on T2WI (B) and on diffusion study (C), hypointense on ADC map (C) with mean ADC value = 0.925 · 103 mm2/s.
The lesion appeared hypointense on arterial phase (E) with delayed contrast enhancement after 30 min from injection(G). Retraction of
the adjacent liver capsule is noted (arrow). The lesion was diagnosed as peripheral cholangiocarcinoma according to the MRI ﬁndings that
conﬁrmed by histopathological study after CT guided biopsy.
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Table 1 Mean apparent diffusion coefﬁcient (ADCs) values of the hepatic focal lesion in this study using different b values.
Lesion 1st sequence 2nd sequence 3rd sequence SD P Sig
Simple cyst 3.63 3.745 3.701 0.121 0.493 NS
Hydatid cyst 3.505 3.335 3.315 0.064 0.262 NS
Hemangioma 3.017 2.897 2.827 0.102 0.223 NS
Adenoma 2.25 2.09 2.05 – – –
FNH 1.85 1.785 1.725 0.021 0.3 NS
HCC 1.368 1.27 1.25 0.05 0.074 NS
CCA 0.925 0.822 0.804 0.11 0.246 NS
Lymphoma 1.37 1.20 1.18 – – –
Metastasis 0.786 0.72 0.695 0.048 0.185 NS
Normal liver tissue 2.89 2.73 2.68 0.58 0.212 NS
Benign lesions 2.942 2.828 2.809 0.651 0.786 NS
Malignant lesions 1.059 0.961 0.921 0.267 0.491 NS
b value = 100, 500 and 750 s/mm2at the 1st, 2nd and 3rd sequences respectively.
NS, non signiﬁcant. SD = Standard Deviation. P= p value.
Table 2 The difference between the mean ADC values of benign and malignant lesions in this study using different b values.
Benign lesions SD Malignant lesions SD P Sig.
First sequence 2.942 0.611 1.059 0.281 <0.001 HS
Second sequence 2.828 0.641 0.961 0.257 <0.001 HS
Third sequence 2.809 0.631 0.921 0.237 <0.001 HS
b value = 100, 500 and 750 s/mm2 at the 1st, 2nd and 3rd sequences respectively.
HS, highly signiﬁcant: SD = Standard Deviation.
 Mean ADC value = (Number · 103 mm2/s) ± SD (Standard deviation).
 The lowest ADCs were found in metastases, CCA and HCCs and the highest values were found in hemangiomas and hepatic cysts.
 The difference between the mean ADC values of benign and malignant lesions was statistically signiﬁcant (P< 0.001). No statistically sig-
niﬁcant differences in ADC values among the different benign lesions or among the different malignant lesions at different sequences.
 P values indicate statically insigniﬁcant differences between the difference sequences.
Table 3 MR signal intensity characteristics of the hepatic focal lesion in this study after dynamic contrast (Gd-DTPA) material–
enhanced imaging (Axial 3D GRE T1).
Lesion Sequence
Arterial phase Portal venous phase Equilibrium phase Delayed phase
Simple cyst ﬂ ﬂ ﬂ ﬂ
Hydatid cyst ﬂ ﬂ ﬂ ﬂ
Hemangioma › › › ›
Adenoma ›* Iso Iso ﬂ
FNH ›* (ﬂ) ›* ›* ﬂ (›)
HCC ›* ﬂ ﬂ ﬂ
CCA ﬂ ﬂ ﬂ Variable
Lymphoma ﬂ ﬂ ›* ›*
Metastasis › ﬂ ﬂ ﬂ
 Arrows indicate increased (‘‘up’’ arrow) or decreased (‘‘down’’ arrow) enhancement relative to the surrounding normal liver.
Arrows in parentheses indicate increased or decreased enhancement in an area of central scarring. Iso = isoenhancing.
 The enhancement pattern of hemangioma at the 7 lesions in this study is an incomplete ring of peripheral nodular enhance-
ment at the arterial phase with gradual ﬁlling at the port-venous and equilibrium phases and complete ﬁlling at the delayed
phase.
* Heterogeneous enhancement.
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lymphoma.DWI (Diffusion-weighted imaging) is a simple and sensitive
method for screening focal hepatic lesions and is useful for dif-
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Chart 1 Mean apparent diffusion coefﬁcient (ADCs) values of
the different hepatic focal lesion in this study using different b
values.
460 M.E. Badawy et al.ferential diagnosis. DW MR imaging enables qualitative and
quantitative assessment of tissue diffusivity. Quantitative anal-
ysis may be performed with the generation of apparent diffu-
sion coefﬁcient (ADC) maps from diffusion images obtained
at different b values (5,12).
Aliya et al. reported that the actual detection of liver tumor
is reported to be greater at low b values (50–150 s/mm2) (12).
Parikh et al. reported a signiﬁcant improvement in the detec-
tion of focal liver lesions with low b-value diffusion-weighted
imaging (88% accuracy) compared with T2-weighted imaging
(70%). High b values are considered to be more important
for the characterization of focal liver lesions; however, the high
signal intensity of a lesion at high b values is most effectively
interpreted in conjunction with the lesion characteristics seen
with other conventional MR sequences (13).
The use of high b value overcomes the effect of capillary
perfusion and water diffusion in extracellular extravascular
space, as high b value will result in the reduction of signal from
moving protons in the bile ducts, cysts, vessels, and ﬂuid in the
bowel. This will result in an increased contrast between the le-
sion and liver. Furthermore, the differences in the relative con-
trast ratio between malignant and benign lesions were
increased with a high b value (14,15).
The absolute ADC values of the different types of lesions
were not similar, which is probably due to differences in tech-
niques applied (b value, breath measurement methods, and
mathematical technique applied). This ﬁnding was also stated
by Petra and Eric eta al where they stated that in spite there are
an increasing number of studies dealing with quantitative mea-
surements of ADC in liver lesions, there are many discrepan-
cies in the reported ADC values where there is no cut-off
value for ADC values in normal parenchyma, benign and
malignant lesions and this is often associated with many tech-
nical parameters such as the use of respiratory-triggered versus
breath- hold diffusion-weighted protocol and signiﬁcantly b
value as high b value results in low ADC value and vice versa
(16), these agreeing with Bachir Taouli et al. who stated that
ADCs tend to be higher when using low b values (17).
The SNR (Signal to noise ratio) of the normal liver was sig-
niﬁcantly better on respiratory-triggered DWI than on breath-
hold DWI. The mean CNR (Contrast to noise ratio) of metas-
tases, hepatocellular carcinomas, and abscesses was signiﬁ-cantly better in the respiratory-triggered DWI than in the
breathhold DWI sequences (18).
This owed to the protocol of DWI in our study, which was
carried by using respiratory-triggered protocol with b value
(100 s/mm2) for proper detection of the hepatic focal lesions
and b value (500 and 750 s/mm2) to overcome the effect of cap-
illary perfusion and water diffusion in extracellular extravascu-
lar space with subsequent reduction of signal from moving
protons.
Yet the ﬁndings in the present work were similar to previ-
ous studies in many aspects, the difference between the mean
ADC values of benign and malignant lesions was statistically
signiﬁcant (P< 0.001) and no statistically signiﬁcant differ-
ences in ADC values among the different benign lesions or
among the different malignant lesions which supports similar
previous ﬁndings where Onura et al. stated that the mean
ADC values of benign lesions were higher than malignant le-
sions and these differences were statistically signiﬁcant for all
3 diffusion gradients with P values of 0.0023, 0.0001, and
<0.0001 (19). These values are agreeing with Miller et al.
who stated that the ADC values of benign hepatic lesions were
signiﬁcantly higher than those of malignant hepatic tumors,
with a P value <0.05 (20). Demir et al. also stated that the dif-
ference between the mean ADC values of benign and malig-
nant lesions was statistically signiﬁcant (P< 0.01) and no
statistically signiﬁcant differences in ADC values among the
different benign lesions or among the different malignant le-
sions (21). Bachir Taouli et-al also stated that the lowest ADCs
were found in metastases, CCA and HCCs and the highest val-
ues were found in hemangiomas and hepatic cysts (17).
5. Conclusion
Diffusion-weighted imaging (DWI) offers the possibility to ob-
tain criteria for characterization of focal liver lesions with sub-
sequent differentiation between benign and malignant hepatic
focal lesions without the need for contrast agent administra-
tion-by quantifying diffusion effects via apparent diffusion
coefﬁcient (ADC) measurements.
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